Catheter Precision Inc (VTAK)
0.64
+0.03
(+5.26%)
USD |
NYAM |
Jun 26, 10:25
Catheter Precision SG&A Expense (TTM): 9.545M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 9.545M |
December 31, 2023 | 17.12M |
September 30, 2023 | 22.35M |
June 30, 2023 | 23.12M |
March 31, 2023 | 24.18M |
December 31, 2022 | 16.25M |
September 30, 2022 | 12.48M |
June 30, 2022 | 13.18M |
March 31, 2022 | 14.10M |
December 31, 2021 | 15.48M |
September 30, 2021 | 17.66M |
June 30, 2021 | 18.15M |
March 31, 2021 | 22.65M |
Date | Value |
---|---|
December 31, 2020 | 25.26M |
September 30, 2020 | 27.52M |
June 30, 2020 | 38.71M |
March 31, 2020 | 44.60M |
December 31, 2019 | 51.55M |
September 30, 2019 | 57.72M |
June 30, 2019 | 47.20M |
March 31, 2019 | 41.02M |
December 31, 2018 | 30.43M |
September 30, 2018 | 18.64M |
June 30, 2018 | 15.17M |
March 31, 2018 | 15.84M |
December 31, 2017 | 14.95M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
9.545M
Minimum
Mar 2024
57.72M
Maximum
Sep 2019
25.94M
Average
22.50M
Median
SG&A Expense (TTM) Benchmarks
Perspective Therapeutics Inc | 19.11M |
Retractable Technologies Inc | 19.28M |
InfuSystems Holdings Inc | 59.82M |
Xtant Medical Holdings Inc | 72.60M |
Asensus Surgical Inc | 34.07M |